SureTrader
Interactive Brokers Advertisement
Home > Boards > Canadian > Biotechs >

Medicenna Therapeutics (mdna)

mdna RSS Feed
Add MDNA Price Alert      Hide Sticky   Hide Intro
Moderator: BioSpecialist
Search This Board: 
Last Post: 9/21/2017 10:27:26 AM - Followers: 1 - Board type: Free - Posts Today: 0

Here is a very attractive and brutally undervalued canadian company called Medicenna (MDNA.TO) which is listed since March thats why its also undicovered . This Cancer Play has a Phase 2 trial in recurrent Glioblastoma ongoing a $650 Million Market , they expect to complete enrollment by year end and to report results in early Q1 2018 . If the results are positive then they can file for accelerated approval in 2H 2018 and this makes this company with a terrible low valuation of only C$ 36 Million a super attractive opportunity which has 10 bagger potential easily on positive phase 2 results in Q1 2018 and FDA approval .Please do your own DD and realize the mega potential .GL


Medicenna Therapeutics (MDNA.TO)

Market Cap C$36 Million
Cash : C$ 20 Million << enough untill Q1 2019
Price : $1.50

Shares Out: 24.3 Million ( 15.5 Million shares held by Insider alone )


Medicenna Therapeutics (TSXV: MDNA) CEO: Our Drug Has Potential for Phase 2 Approval
https://smallcappower.com/videos/companies-to-watch/medicenna-therapeutics-tsxv-mdna/



New Presentation
http://s21.q4cdn.com/710416940/files/doc_presentations/2017/Medicenna-Corporate-Presentation-Q3-2017.pdf


Fact Sheet
http://s21.q4cdn.com/710416940/files/doc_downloads/fact_sheet/Medicenna-FS-Q1-2017-v2.pdf

Insider Ownership :

Aries Biologics, Inc. 5 500 000
Rosemina Merchant 5 050 000
Fahar Merchant 5 050 000
Elizabeth Williams 5 300
Chandrakant J. Panchal, PhD 1 000
Trevor P. Wong-Chor 714



\


\




 
SureTrader
Interactive Brokers Advertisement
mdna
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
mdna News: Medicenna Announces Trading on the OTCQX Best Market in the United States 10/18/2017 07:00:00 AM
mdna News: Medicenna Announces Trading on the OTCQX Best Market in the United States 10/18/2017 07:00:00 AM
mdna News: OTC Markets Group Welcomes Medicenna Therapeutics to OTCQX 10/18/2017 07:00:00 AM
mdna News: Medicenna Presents Clinical Data on Initial Experience from Ongoing Phase 2b Study of MDNA55 10/10/2017 10:49:00 AM
mdna News: Medicenna Presents Clinical Data on Initial Experience from Ongoing Phase 2b Study of MDNA55 10/10/2017 10:49:00 AM
PostSubject
#1   Nice move yesterday .. BioSpecialist 09/21/17 10:27:25 AM
PostSubject